SIFI Announces the Granting of a Second FDA Orphan Drug Designation for Polihexanide in Fungal…
CATANIA, Italy, March 14, 2022 /PRNewswire/ -- SIFI S.p.A. ("SIFI" or the "Company"), a leading international ophthalmic pharmaceutical company, announced today that the U.S. Food and Drug Administration ("FDA") has approved the company's…